Try our beta test site
44 studies found for:    eisai alzheimer's
Show Display Options
Rank Status Study
1 Completed EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Aricept
2 Completed
Has Results
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aricept (donepezil SR 23 mg);   Drug: Aricept (donepezil IR 10 mg)
3 Completed
Has Results
Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: 23 mg SR in Study 326;   Drug: 10 mg IR in Study 326
4 Completed A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study
Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A;   Drug: Placebo Comparator B;   Drug: Active Comparator B;   Drug: Placebo Comparator A
5 Completed
Has Results
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil
6 Recruiting Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
Conditions: Alzheimer Disease;   Dementia, Alzheimer Type
Interventions: Drug: E2609;   Drug: Placebo
7 Completed The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Condition: Mild to Severe Alzheimer's Disease
Intervention: Drug: Donepezil HCl
8 Active, not recruiting A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg/kg;   Drug: BAN2401 5.0 mg/kg;   Drug: BAN2401 10 mg/kg
9 Recruiting A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: elenbecestat;   Drug: Placebo
10 Recruiting A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Condition: Alzheimer's Disease
Interventions: Drug: elenbecestat;   Drug: Placebo
11 Completed Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
12 Completed Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: Donepezil hydrochloride
13 Completed A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Interventions: Drug: E2020;   Drug: Placebo
14 Completed Alzheimer's Disease Long-term Follow-up Study (ALF Study)
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride
15 Completed Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride
16 Recruiting Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia
Condition: Irregular Sleep-Wake Rhythm Disorder
Interventions: Drug: Lemborexant 2.5 mg;   Drug: Lemborexant 5 mg;   Drug: Lemborexant 10 mg;   Drug: Lemborexant 15 mg;   Drug: Lemborexant-matched placebo
17 Completed Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
18 Completed
Has Results
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020
19 Completed Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020
20 Completed Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Conditions: Dementia;   Alzheimer's Disease
Intervention: Drug: Rasagiline

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.